Evidence map›Paper›PMID 32162447›Full record

ArticleAnnals of clinical and translational neurology2020

Brain metabolic alterations herald falls in patients with Parkinson's disease.

Ioannis U Isaias, Joachim Brumberg, Nicoló G Pozzi, Chiara Palmisano, Andrea Canessa, Giorgio Marotta, Jens Volkmann, Gianni Pezzoli

Open access · goldAbstract read
In one paragraph

Article in Annals of clinical and translational neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Positron emission tomography neuroimaging of [Frontiers in neuroscience · 2024
    Article
  7. Salience network and cognitive impairment in Parkinson's disease.medRxiv : the preprint server for health sciences · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Ioannis U IsaiasDepartment of Neurology, University Hospital and Julius Maximilian University of Würzburg, Würzburg, Germany.ORCID 0000-0002-3552-5144
Joachim BrumbergDepartment of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany.
Nicoló G PozziDepartment of Neurology, University Hospital and Julius Maximilian University of Würzburg, Würzburg, Germany.
Chiara PalmisanoDepartment of Neurology, University Hospital and Julius Maximilian University of Würzburg, Würzburg, Germany.
Andrea CanessaFondazione Europea di Ricerca Biomedica (FERB Onlus), Cernusco s/N (Milano), Italy.
Giorgio MarottaDepartment of Nuclear Medicine, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milano, Italy.ORCID 0000-0002-5945-8628
Jens VolkmannDepartment of Neurology, University Hospital and Julius Maximilian University of Würzburg, Würzburg, Germany.
Gianni PezzoliCentro Parkinson ASST G. Pini-CTO, Milano, Italy.
University of Würzburg · DEFondazione Europea Ricerca Biomedica · ITFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITIstituto Ortopedico Gaetano Pini · ITUniversitätsklinikum Würzburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pathophysiological understanding of gait and balance disorders in Parkinson's disease is insufficient and late recognition of fall risk limits efficacious follow-up to prevent or delay falls. We show a distinctive reduction of glucose metabolism in the left posterior parietal cortex, with increased metabolic activity in the cerebellum, in parkinsonian patients 6-8 months before their first fall episode. Falls in Parkinson's disease may arise from altered cortical processing of body spatial orientation, possibly predicted by abnormal cortical metabolism.

Indexed as

Accidental FallsAgedCerebellumFemaleFluorodeoxyglucose F18Follow-Up StudiesGlucoseHumansMaleMiddle AgedParietal LobeParkinson DiseasePositron-Emission TomographyRadiopharmaceuticalsFluorodeoxyglucose F18GlucoseRadiopharmaceuticals

Identifiers

PMID32162447
PMCPMC7187714
OpenAlexW3011282269

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.